✦ LIBER ✦

Pegylated interferon-α2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabetes mellitus

✍ Scribed by Hiroaki Yagyu; Kenta Okada; Shin Sato; Yumiko Yamashita; Nobukazu Okada; Jun-ichi Osuga; Shoichiro Nagasaka; Kentaro Sugano; Shun Ishibashi

Book ID: 118435529
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 273 KB
Volume: 95
Category: Article
ISSN: 0168-8227
DOI: 10.1016/j.diabres.2011.11.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dual onset of type 1 diabetes mellitus a

Dual onset of type 1 diabetes mellitus and Graves’ disease during treatment with pegylated interferon α-2b and ribavirin for chronic hepatitis C

✍ Masayuki Hayashi; Yuko Kataoka; Kazushige Tachikawa; Hiroki Koguchi; Hiroshi Tan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Onset of Type 1 Diabetes Mellitus During

Onset of Type 1 Diabetes Mellitus During Pegylated-interferon Alfa and Ribavirin Therapy for Chronic Hepatitis C Virus Infection

✍ Raghini Ranganathan; Krishnaveni Janarthanan; Senthilkumar Rajasekaran 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 129 KB

Re-treatment virologic response in chron

Re-treatment virologic response in chronic hepatitis C virologic non-responders (NR) and responder-relapsers (NR) to interferon (IFN) monotherapy: IFN α-2b induction followed by combination ribavirin/interferon α-2b vs combination ribavirin/interferon α-2b (780 MIU/52 weeks rebetron therapy)

✍ Pimstone, Neville R.; Canio, John B.; Chiang, Michelle H.; Kokosinski, Janet; Po 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 184 KB